[Progress in antibacterial chemotherapy].
D001424:Bacterial Infections / Q000188:drug therapy*; D002228:Carbenicillin / Q000627:therapeutic use*; D002435:Cefamandole / Q000627:therapeutic use; D002437:Cefazolin / Q000627:therapeutic use; D002440:Cefoxitin / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004927:Escherichia coli Infections / Q000188:drug therapy; D006801:Humans; D007710:Klebsiella Infections / Q000188:drug therapy; D010406:Penicillins / Q000627:therapeutic use; D013982:Ticarcillin / Q000627:therapeutic use
D002511:Cephalosporins; D010406:Penicillins; D002435:Cefamandole; D002440:Cefoxitin; D013982:Ticarcillin; D002228:Carbenicillin; D002437:Cefazolin
Fortschritte in der antibakteriellen Chemotherapie.